Most sold healthcare stocks in Q3 2024

See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2024, measured as net reductions in reported share positions from Q2 2024 into Q3 2024. Notable reductions at the top of this list include TELADOC HEALTH INC (TDOC), STANDARD BIOTOOLS INC (LAB), CAREDX INC (CDNA), GE HEALTHCARE TECHNOLOGY (GEHC). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
TDOCTELADOC HEALTH INC-8,076,038-$82.05M01415
LABSTANDARD BIOTOOLS INC-4,533,184$2.82M00203
CDNACAREDX INC-3,364,792$23.38M00303
GEHCGE HEALTHCARE TECHNOLOGY-3,279,255$122.18M047113
PFEPFIZER INC-3,034,922-$57.84M21110125
SGRYSURGERY PARTNERS INC-2,941,523-$67.87M00111
FDMT4D MOLECULAR THERAPEUTICS IN-2,934,914-$61.60M00010
VERVVERVE THERAPEUTICS INC-2,835,777-$13.86M01011
LFSTLIFESTANCE HEALTH GROUP INC-1,713,677$14.23M10203
ABTABBOTT LABORATORIES-1,695,005$87.09M278122
VCYTVERACYTE INC-1,689,112$31.95M11204
NVONOVO-NORDISK A/S-SPONS ADR-1,579,448-$616.38M036012
WBAWALGREENS BOOTS ALLIANCE INC-1,570,598-$25.36M13307
GILDGILEAD SCIENCES INC-1,528,357$508.95M2312017
JNJJOHNSON & JOHNSON-1,516,993-$95.60M11110328
FTREFORTREA HOLDINGS INC-1,510,367-$15.54M00313
CERSCERUS CORP-1,326,153-$2.71M01102
MPLNMULTIPLAN CORP-1,216,000-$472.29K00010
ME23ANDME HOLDING CO -CLASS A-1,137,918-$582.32K00102
SNYSANOFI-ADR-1,107,097$649.40M04419
ALLOALLOGENE THERAPEUTICS INC-1,105,946-$2.27M00102
BEAMBEAM THERAPEUTICS INC-1,101,722-$18.82M00202
HLNHALEON PLC-ADR-1,093,446$414.75M02408
IRWDIRONWOOD PHARMACEUTICALS INC-1,078,925-$27.67M01011
INSMINSMED INC-1,034,070-$69.27M10011
MRSNMERSANA THERAPEUTICS INC-955,500-$1.98M00101
UNHUNITEDHEALTH GROUP INC-951,670$867.00M21717540
VXRTVAXART INC-919,631-$607.67K00112
SRDXSURMODICS INC-912,602-$39.29M00212
AUTLAUTOLUS THERAPEUTICS PLC-891,185-$3.06M01103
CRBUCARIBOU BIOSCIENCES INC-887,387-$1.26M10102
GERNGERON CORP-781,723-$3.31M00010
CARACARA THERAPEUTICS INC-779,494-$90.01K01102
STIMNEURONETICS INC-779,409-$2.01M01011
BCABBIOATLA INC-748,059-$825.39K00111
DXCMDEXCOM INC-743,045-$184.13M04318
CAHCARDINAL HEALTH INC-729,472-$35.78M045211
BFLYBUTTERFLY NETWORK INC-704,581$9.45M01304
AAGILENT TECHNOLOGIES INC-695,697$26.01M02609
MCKMCKESSON CORP-639,768-$419.81M225411
EWEDWARDS LIFESCIENCES CORP-611,490-$117.28M346014
VKTXVIKING THERAPEUTICS INC-603,169-$22.55M12104
HUMAHUMACYTE INC-600,300-$2.88M00010
MASS908 DEVICES INC-591,182-$9.00M01102
CHECHEMED CORP-563,695-$303.03M20113
EXASEXACT SCIENCES CORP-561,020-$12.55M12508
TWSTTWIST BIOSCIENCE CORP-556,526-$50.27M20113
TMOTHERMO FISHER SCIENTIFIC INC-537,538$131.30M1811121
QSIQUANTUM-SI INC-536,764-$2.56M10112
ESPRESPERION THERAPEUTICS INC-507,800-$1.81M00102
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−8.9M−6.7M−4.4M−2.2M0.00Net change in reported shares (all institutional filers)TDOCLABCDNAGEHCPFESGRYFDMTVERVLFSTABTVCYTNVOWBAGILDJNJFTRECERSMPLNMESNYSymbol

Frequently asked questions about Most sold healthcare stocks in Q3 2024

  • What are the most sold Healthcare stocks in Q3 2024?

    The most sold healthcare stocks in Q3 2024 are those with the largest decrease in reported share counts across institutional investors compared to Q2 2024, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2024?

    Among filers in this sector, net reductions were largest in companies such as TELADOC HEALTH INC (TDOC), STANDARD BIOTOOLS INC (LAB), CAREDX INC (CDNA), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2024).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.